97 related articles for article (PubMed ID: 15078166)
1. Amyloid accomplices and enforcers.
Alexandrescu AT
Protein Sci; 2005 Jan; 14(1):1-12. PubMed ID: 15576561
[TBL] [Abstract][Full Text] [Related]
2. Binding with nucleic acids or glycosaminoglycans converts soluble protein oligomers to amyloid.
Di Domizio J; Zhang R; Stagg LJ; Gagea M; Zhuo M; Ladbury JE; Cao W
J Biol Chem; 2012 Jan; 287(1):736-747. PubMed ID: 22102410
[TBL] [Abstract][Full Text] [Related]
3. Amyloid fibril cytotoxicity and associated disorders.
Saremi S; Khajeh K
Prog Mol Biol Transl Sci; 2024; 206():265-290. PubMed ID: 38811083
[TBL] [Abstract][Full Text] [Related]
4. Native State Stabilization of Amyloidogenic Proteins by Kinetic Stabilizers: Inhibition of Protein Aggregation and Clinical Relevance.
Xx P; Raymandal B; Mondal S
ChemMedChem; 2024 Jun; ():e202400244. PubMed ID: 38863235
[TBL] [Abstract][Full Text] [Related]
5. Competition between inside-out unfolding and pathogenic aggregation in an amyloid-forming β-propeller.
Saccuzzo EG; Mebrat MD; Scelsi HF; Kim M; Ma MT; Su X; Hill SE; Rheaume E; Li R; Torres MP; Gumbart JC; Van Horn WD; Lieberman RL
Nat Commun; 2024 Jan; 15(1):155. PubMed ID: 38168102
[TBL] [Abstract][Full Text] [Related]
6. The Promising Role of Selenium and Yeast in the Fight Against Protein Amyloidosis.
Kieliszek M; Sapazhenkava K
Biol Trace Elem Res; 2024 Jun; ():. PubMed ID: 38829477
[TBL] [Abstract][Full Text] [Related]
7. Investigating the Neuroprotective Effects of Turmeric Extract: Structural Interactions of β-Amyloid Peptide with Single Curcuminoids.
Randino R; Grimaldi M; Persico M; De Santis A; Cini E; Cabri W; Riva A; D'Errico G; Fattorusso C; D'Ursi AM; Rodriquez M
Sci Rep; 2016 Dec; 6():38846. PubMed ID: 28004737
[TBL] [Abstract][Full Text] [Related]
8. Natural history and therapy of AL cardiac amyloidosis.
Grogan M; Dispenzieri A
Heart Fail Rev; 2015 Mar; 20(2):155-62. PubMed ID: 25447844
[TBL] [Abstract][Full Text] [Related]
9. Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.
Ashraf GM; Greig NH; Khan TA; Hassan I; Tabrez S; Shakil S; Sheikh IA; Zaidi SK; Akram M; Jabir NR; Firoz CK; Naeem A; Alhazza IM; Damanhouri GA; Kamal MA
CNS Neurol Disord Drug Targets; 2014; 13(7):1280-93. PubMed ID: 25230234
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of agents for targeting visceral amyloid.
Wall JS; Solomon A; Kennel SJ
Tijdschr Nucl Geneeskd; 2011 Dec; 33(4):807-814. PubMed ID: 23885194
[TBL] [Abstract][Full Text] [Related]
11. The role of amyloidogenic protein oligomerization in neurodegenerative disease.
Lotz GP; Legleiter J
J Mol Med (Berl); 2013 Jun; 91(6):653-64. PubMed ID: 23529761
[TBL] [Abstract][Full Text] [Related]
12. Polyglutamine misfolding in yeast: toxic and protective aggregation.
Duennwald ML
Prion; 2011; 5(4):285-90. PubMed ID: 22052348
[TBL] [Abstract][Full Text] [Related]
13. Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils.
Giorgetti S; Raimondi S; Pagano K; Relini A; Bucciantini M; Corazza A; Fogolari F; Codutti L; Salmona M; Mangione P; Colombo L; De Luigi A; Porcari R; Gliozzi A; Stefani M; Esposito G; Bellotti V; Stoppini M
J Biol Chem; 2011 Jan; 286(3):2121-31. PubMed ID: 21068391
[TBL] [Abstract][Full Text] [Related]
14. Cross currents in protein misfolding disorders: interactions and therapy.
Morales R; Green KM; Soto C
CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):363-71. PubMed ID: 19702573
[TBL] [Abstract][Full Text] [Related]
15. Computational selection of inhibitors of Abeta aggregation and neuronal toxicity.
Chen D; Martin ZS; Soto C; Schein CH
Bioorg Med Chem; 2009 Jul; 17(14):5189-97. PubMed ID: 19540126
[TBL] [Abstract][Full Text] [Related]
16. The relevance of the aldehyde bisulfite toluidine blue reaction and its variants in the submicroscopic carbohydrate research.
Makovitzky J; Richter S
Acta Histochem; 2009; 111(4):273-91. PubMed ID: 19157525
[TBL] [Abstract][Full Text] [Related]
17. Meeting report: Structural determination of environmentally responsive proteins.
Reinlib L
Environ Health Perspect; 2005 Nov; 113(11):1622-6. PubMed ID: 16263521
[TBL] [Abstract][Full Text] [Related]
18. Protein folding pathology in domestic animals.
Gruys E
J Zhejiang Univ Sci; 2004 Oct; 5(10):1226-38. PubMed ID: 15362194
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical strategies against amyloidosis: old and new drugs in targeting a "protein misfolding disease".
De Lorenzi E; Giorgetti S; Grossi S; Merlini G; Caccialanza G; Bellotti V
Curr Med Chem; 2004 Apr; 11(8):1065-84. PubMed ID: 15078166
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
